Brainstorm Issues 2017 Letter to Shareholders

December 29, 2017

Responsive image

HACKENSACK, N.J. and PETACH TIKVAH, Israel, Dec. 29, 2017 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to Shareholders from its President and CEO, Chaim Lebovits…

Category: Precious Metals